newsfilter
← Latest News
GlobeNewswire·

Pardes Biosciences to Present at J.P. Morgan Healthcare Conference

CARLSBAD, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ:PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential novel direct-acting, oral antiviral drug candidate for the treatment and preventio